Abhay Joshi

Insider Reports History

Location
Newark, CA
Signature
/s/ Terri McDowell, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Abhay Joshi:

Company Role Class Num Shares Value Price $ Report Date Ownership
Revance Therapeutics, Inc. COO, President of R&D Common Stock 120,708 $901,689 $7.47 15 Mar 2022 Direct

Insider Reports Filed by Abhay Joshi

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000120919122019727-joshi-abhay-2022-03-15 Revance Therapeutics, Inc. 15 Mar 2022 1 -$41,165 4 COO, President of R&D 17 Mar 2022, 17:56
/report/000147929022000023-joshi-abhay-2022-02-15 Revance Therapeutics, Inc. 15 Feb 2022 2 -$67,458 4 COO, President, R&D 17 Feb 2022, 19:51